0001104659-23-088448.txt : 20230807 0001104659-23-088448.hdr.sgml : 20230807 20230807181145 ACCESSION NUMBER: 0001104659-23-088448 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230804 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucsok Anna CENTRAL INDEX KEY: 0001843904 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38804 FILM NUMBER: 231148810 MAIL ADDRESS: STREET 1: 9555 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZYNEX INC CENTRAL INDEX KEY: 0000846475 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 870403828 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9655 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: (800)-495-6670 MAIL ADDRESS: STREET 1: 9655 MAROON CIRCLE CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20050812 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20040120 FORMER COMPANY: FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC DATE OF NAME CHANGE: 20031126 4 1 tm2323090-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-04 0 0000846475 ZYNEX INC ZYXI 0001843904 Lucsok Anna C/O ZYNEX, INC. 9655 MAROON CIRCLE ENGLEWOOD CO 80112 0 1 0 0 Chief Operating Officer 0 Common Stock 2023-08-04 4 S 0 12000 8.41 D 17840 D Common Stock 2023-08-07 4 F 0 256 8.03 D 18275 D On August 4, 2023, Anna Lucsok, sold an aggregate of 12,000 shares of common stock in open market transactions at a price per share equal to $8.41. The price per share equal to $8.41 represents the weighted average sales price for the shares. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares sold at each separate price. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of Restricted Stock Awards ("RSAs") and does not represent a sale. /s/ Anna Lucsok 2023-08-07